Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12102445 Monitoring and communicating information using drug administration devices

Patent 12102445 was granted and assigned to Janssen Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Janssen Pharmaceuticals

Current Assignee

Janssen Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121024450

Patent Inventor Names

Monica A. Kapil0

Emma L. Hubert0

Frederick E. Shelton, IV0

Jason L. Harris0

Date of Patent

October 1, 2024

Patent Application Number

170688650

Date Filed

October 13, 2020

Patent Citations

‌

US Patent 9168000 Meal detection devices and methods

‌

US Patent 9314808 Fluid delivery device

‌

US Patent 9427580 Devices and methods for the treatment of metabolic disorders

‌

US Patent 9555950 Fluid product dispensing device

‌

US Patent 9984211 Clinical information management system

‌

US Patent 10456534 Nasal spray delivery guide

‌

US Patent 10733267 Surgical data control system

‌

US Patent 10569071 Medicant eluting adjuncts and methods of using medicant eluting adjuncts

...

Patent Primary Examiner

‌

Manuel A Mendez

Patent abstract

In general, systems and methods for monitoring and communicating information using drug administration devices are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12102445 Monitoring and communicating information using drug administration devices

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API